NHS England recommends prescribing pen needles under £5 per box1. In a recent analysis, we found that less than 5% of CCGs have a mean average price of less than £52.
Insupen Original is priced at £2.49 (Pack of 100), complies with ISO 11608 and additional self-imposed quality tests, to ensure quality without compromise3,4.
From June 2022, we are introducing a 4mm x 33G needle to the range making Insupen Original the finest and most cost-effective pen needle range on the market. The 4mm x 33g offers patients the option of a pen needle designed to minimise discomfort at a ground-breaking sustainable price to the NHS of £2.49.
Make prescribing savings quickly
Spirit offers a FREE implementation service to drive down the cost of prescribing, without impacting your valuable time and resources.
The average CCG can save 43% on their annual pen needle spend by adopting Insupen Original2.
Making use of our Active Implementation service has been proven to deliver 700% greater savings than when leaving prescription changes to be managed at practice level without support5. We are experts at mobilisation and do the work for you. Other patient reviews can be conducted at the same time.
Insupen Original is available in 5 lengths and 5 gauges to match patient need. They are precision engineered to reduce friction points and have a wide internal diameter for efficient insulin administration.
Download our Insupen Original information leaflet.
1. Items which should not routinely be prescribed in primary care: Guidance for CCGs version 2, June 2019 NHS England Publishing Approval Reference 000608
2. Insulin Pen Needle Cost Savings Analysis. Data on file, Spirit Healthcare, Dec 2021
3. Data on file, Spirit Healthcare. Pikdare quality standards and testing data, supplied April 2020
4. Comparison of usability and Patient Preference for insulin Pen Needles produced with different production Techniques:”Thin-Wall” Needles compared to “Regular-Wall” Needles: An Open-Label Study, Thorsten Siegmund, M.D., Hannes Blankenfeld, M.D., and Petra-Maria Schumm-Draeger,M.D.,
Diabetes Technology & Therapeutics. August 2009,11 (8):523-528. doi: 10.1089/dia. 2009. 0048. Published in Volume: 11 Issue 8: August 21, 2009
5. Jim Swift et al, “Implementing formulary change in diabetes”, British Journal of Healthcare Management, Vol. 23, No. 4
How much could you save?
Try our cost calculator below. Based on the products we have available in our portfolio it will demonstrate how much money we can potentially save your CCG.
Aneurin Bevan HB
Ayrshire and Arran
Bath and North East Somerset, Swindon and Wiltshire ICB
Bedfordshire, Luton and Milton Keynes ICB
Betsi Cadwaladr University HB
Birmingham and Solihull ICB
Black Country ICB
Bristol, North Somerset and South Gloucestershire ICB
Buckinghamshire, Oxfordshire and Berkshire West ICB
Cambridgeshire and Peterborough ICB
Cardiff and Vale University HB
Cheshire and Merseyside ICB
Cornwall and The Isles of Scilly ICB
Coventry and Warwickshire ICB
Cwm Taf Morgannwg HB
Derby and Derbyshire ICB
Dumfries and Galloway
Greater Glasgow and Clyde
Greater Manchester ICB
Hampshire and Isle of Wight ICB
Herefordshire and Worcestershire ICB
Hertfordshire and West Essex ICB
Humber and North Yorkshire ICB
Hywel Dda HB
Kent and Medway ICB
Lancashire and South Cumbria ICB
Leicester, Leicestershire and Rutland ICB
Mid and South Essex ICB
Norfolk and Waveney ICB
North Central London ICB
North East and North Cumbria ICB
North East London ICB
North West London ICB
Nottingham and Nottinghamshire ICB
Powys Teaching HB
Shropshire, Telford and Wrekin ICB
South East London ICB
South Eastern Area
South West London ICB
South Yorkshire ICB
Staffordshire and Stoke-on-Trent ICB
Suffolk and North East Essex ICB
Surrey Heartlands ICB
Swansea Bay University HB
West Yorkshire ICB
Based on ICB prescribing data from Jul 2022 – June 2023 with a 70% switch from current prescribing to comparable products from Spirit Healthcare.